Avanos Medical Inc. (NYSE:AVNS) Q2 2023 Results Conference Call August 9, 2023 9:00 AM ET
Company Participants
Joe Woody - CEO and Director
Scott Galovan - Vice President of Strategy and Corporate Development
Michael Greiner - Senior VP, CFO and Chief Transformation Officer
Conference Call Participants
Rick Wise - Stifel
Matthew Mishan - KeyBanc
Kristen Stewart - CL King
Daniel Stauder - JMP Securities
Operator
Good morning, everyone, and welcome to the Avanos Second Quarter 2023 Earnings Conference Call. All participants are in a listen-only mode. [Operator Instructions] After today’s prepared remarks there will be opportunity to ask questions. [Operator Instruction] Please Note, today's call is being recorded.
At this time, I'd like to hand the floor over to Avanos CEO, Joe Woody.
Joe Woody
Good morning, everyone. This is Joe Woody. We've asked the New York Stock Exchange, and they agreed to halt our trading as our results were inaccurately reported by one news outlet and possibly more. Our total results inclusive of respiratory health were $199.8 million in revenue and we delivered $0.37 of EPS. Throughout the day today, we're going to work with the various agencies and news outlets to correct the information.
Now I'm going to turn the call over to Scott Galovan to begin our prepared remarks. Thank you.
Scott Galovan
Good morning, everyone, and thanks for joining us. It's my pleasure to welcome you to 2023 second quarter earnings conference call. Presenting today will be Joe Woody, CEO; and Michael Greiner, Senior Vice President, CFO and Chief Transformation Officer.
Joe will review our second quarter and expectations for the remainder of 2023 as well as provide further insights around the strategy we laid out at our Investor Day in June. Mike will provide additional detail regarding these topics and provide an update of our 2023 planning assumptions given our respiratory health business discontinued operations. We'll finish the call with Q&A. A presentation for today's call is available on the Investors section of our website, avanos.com.
As a reminder, our comments today contain forward-looking statements related to the company, our expected performance, current economic conditions and our industry. No assurance can be given as to future financial results. Actual results could differ materially from those in the forward-looking statements. For more information about forward-looking statements and the risk factors that could influence future results, please see today's press release and risk factors described in our filings with the SEC. Additionally, we will be referring to adjusted results and outlook. The press release has information on these adjustments and reconciliations to comparable GAAP financial measures.